UPDATE: 15 States Considering Interstate Medical Licensure Compact

In response to the finalization of the Federation of State Medical Boards' (FSMB) Interstate Medical Licensure Compact, several states and large healthcare organizations, such as the American Medical Association (AMA), have expressed support and the possibility of endorsement. According to Humayan Chaudhry, DO, president and CEO of the FSMB, “many stakeholders across the spectrum [are] expressing support.” Read here for a full account of the latest developments.

This post is a follow-up to previous posts on September 9 and August 7 regarding the FSMB's proposed interstate compact. Scroll down to learn more.

Hydrocodone Combo Products Moved from Schedule III to Schedule II: What It Means For You

Beginning on October 6, 2014, hydrocodone combination products (HCPs) will be moved from Schedule III to Schedule II substances at the recommendation of the Secretary of the Department of Health & Human Services. This change was included in the Federal Register as part of the Drug Enforcement Agency’s recent publication of its final rule on the matter.  Read here for important need-to-know information on what this change means for family physicians and their patients.

UPDATE: FSMB Compact Proposal Released

According to an article by ModernHealthcare.com, the Federation of State Medical Boards (FSMB) has released its finalized plan for an interstate compact for physician licensure “under which physicians who are licensed in one state can use a streamlined process to be quickly licensed in another.” (Read the full article here)

This post is a follow-up to the August 7, 2014 post regarding FSMB’s initial proposal for this interstate compact. Scroll down to view the original post.